Curcumin nanodisk-induced apoptosis in mantle cell lymphoma

References

• Bosch F, Jares P, Campo E, et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 1994;84:2726–2732.
   PubMed Web of Science ®Google Scholar
• Hartmann EM, Ott G, Rosenwald A. Molecular biology and genetics of lymphomas. Hematol Oncol Clin North Am 2008;22:807–823.
   PubMed Web of Science ®Google Scholar
• Bertoni F, Ponzoni M. The cellular origin of mantle cell lymphoma. Int J Biochem Cell Biol 2007;39:1747–1753.
   PubMed Web of Science ®Google Scholar
• Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 2005;70:700–713.
   PubMed Web of Science ®Google Scholar
• Hussain AR, Ahmed M, Al-Jomah NA, et al. Curcumin suppresses constitutive activation of nuclear factor-KB and requires functional Bax to induce apoptosis in Burkitt’s lymphoma cell lines. Mol Cancer Ther 2008;7:3318–3329.
   PubMed Web of Science ®Google Scholar
• Tan TW, Tsai HR, Lu HF, et al. Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation. Anticancer Res 2006;26:4361–4371.
   PubMed Web of Science ®Google Scholar
• Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa B alpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 2003;101:1053–1062.
   PubMed Web of Science ®Google Scholar
• Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G. Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 2002;512:334–340.
   PubMed Web of Science ®Google Scholar
• Shankar S, Srivastava RK. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer. Int J Oncol 2007;30:905–918.
   PubMed Web of Science ®Google Scholar
• Choudhuri T, Pal S, Das T, Sa G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 2005;280:20059–20068.
   PubMed Web of Science ®Google Scholar
• Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 2008;14:4491–4499.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Sethi G, Baladandayuthapani V, Krishnan S, Shishodia S. Targeting cell signaling pathways for drug discovery: an old lock needs a new key. J Cell Biochem 2007;102:580–592.
   PubMed Web of Science ®Google Scholar
• Ghosh M, Singh ATK, Sulchek T, Gordon LI, Ryan RO. Curcumin nanodisks: formulation and characterization. Nanomedicine 2011;7:162–167.
   PubMed Web of Science ®Google Scholar
• Redmond KA, Nguyen T-S, Ryan RO. All-trans-retinoic acid nanodisks. Int J Pharm 2007;339:246–250.
   PubMed Web of Science ®Google Scholar
• Ryan RO. Nanodisks: hydrophobic drug delivery vehicles. Expert Opin Drug Deliv 2008;5:343–351.
   PubMed Web of Science ®Google Scholar
• Iovannisci DM, Beckstead JA, Ryan RO. Targeting nanodisks via a single chain variable antibody--apolipoprotein chimera. Biochem Biophys Res Commun 2009;379:466–469.
   PubMed Web of Science ®Google Scholar
• Ryan RO, Forte TM, Oda MN. Optimized bacterial expression of human apolipoprotein A-I. Protein Expr Purif 2003;27:98–103.
   PubMed Web of Science ®Google Scholar
• Singh AT, Evens AM, Anderson RJ, et al. All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma. Br J Haematol 2010;150:158–169.
   PubMed Web of Science ®Google Scholar
• Fruehauf JP, Meyskens FLJr. Reactive oxygen species: a breath of life or death? Clin Cancer Res 2007;13:789–794.
   PubMed Web of Science ®Google Scholar
• Kim SW, Oleksyn DW, Rossi RM, et al. Protein kinase C-associated kinase is required for NF-κB signaling and survival in diffuse large B-cell lymphoma cells. Blood 2008;111:1644–1653.
   PubMed Web of Science ®Google Scholar
• Dijkers PF, Medema RH, Pals C, et al. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27 (KIP1). Mol Cell Biol 2000;20:9138–9148.
   PubMed Web of Science ®Google Scholar
• Rummel MJ, de Vos S, Hoelzer D, et al. Altered apoptosis pathways in mantle cell lymphoma. Leuk Lymphoma 2004;45:49–54.
   PubMed Web of Science ®Google Scholar
• Agarwal B, Naresh KN. Bcl-2 family of proteins in indolent B-cell non-Hodgkin’s lymphoma: study of 116 cases. Am J Hematol 2002;70:278–282.
   PubMed Web of Science ®Google Scholar
• Rudelius M, Pittaluga S, Nishizuka S, et al. Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 2006;108:1668–1676.
   PubMed Web of Science ®Google Scholar
• Lee DS, Lee MK, Kim JH. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells. Anticancer Res 2009;29:5039–5044.
   PubMed Web of Science ®Google Scholar
• Uddin S, Hussain AR, Manogaran PS, et al. Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene 2005;24:7022–7030.
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Parent L, Maniatis T. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 1996;84:853–862.
   PubMed Web of Science ®Google Scholar
• Pérez-Galán P, Roué G, Villamor N, Montserrat E, Campo E, Colomer D. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 2006;107:257–264.
   PubMed Web of Science ®Google Scholar
• Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 2002;23:143–150.
   PubMed Web of Science ®Google Scholar
• Fang J, Lu J, Holmgren A. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem 2005;280:25284–25290.
   PubMed Web of Science ®Google Scholar
• Mukerjee A, Vishwanatha JK. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res 2009;29:3867–3875.
   PubMed Web of Science ®Google Scholar
• Ma Z, Haddadi A, Molavi O, Lavasanifar A, Lai R, Samuel J. Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Res 2008;86: 300–310.
   Google Scholar